Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-10
DOI
10.3389/fimmu.2018.01803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection
- (2018) Olena Shtanko et al. ANTIVIRAL RESEARCH
- The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
- (2018) Annika E. Röcker et al. ANTIVIRAL RESEARCH
- Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world
- (2018) Minakshi Prasad et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential Disruption of Ebola Virus Matrix by Graphene Nano-Sheets
- (2018) Rudramani Pokhrel et al. BIOPHYSICAL JOURNAL
- Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects
- (2018) Kuldeep Dhama et al. CURRENT DRUG METABOLISM
- Ibuprofen as a template molecule for drug design against Ebola virus
- (2018) Veljjko Veljkovic Frontiers in Bioscience-Landmark
- Intramuscular Adeno-Associated Virus–Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice
- (2018) Laura P van Lieshout et al. JOURNAL OF INFECTIOUS DISEASES
- G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy
- (2018) Emanuela Ruggiero et al. NUCLEIC ACIDS RESEARCH
- Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry
- (2018) Shirley Qiu et al. VIROLOGY
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
- (2018) Arban Domi et al. Scientific Reports
- Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice
- (2018) Shoufeng Ren et al. Frontiers in Microbiology
- Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
- (2018) Watee Seesuay et al. Emerging Microbes & Infections
- Small Animal Models for Evaluating Filovirus Countermeasures
- (2018) Logan Banadyga et al. ACS Infectious Diseases
- Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
- (2018) Shu Yang et al. Cell Discovery
- From bench to almost bedside: the long road to a licensed Ebola virus vaccine
- (2017) Gary Wong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The ongoing evolution of antibody-based treatments for Ebola virus infection
- (2017) Emelissa J Mendoza et al. Immunotherapy
- Clinical Presentation and Care of Patients with Ebola Virus Disease in the China Ebola Treatment Unit, Liberia
- (2017) Xiaoping Shao et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Ebola virus disease: An update on current prevention and management strategies
- (2017) M.A. Trad et al. JOURNAL OF CLINICAL VIROLOGY
- Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease
- (2017) Michelle Meyer et al. JOURNAL OF INFECTIOUS DISEASES
- First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease
- (2017) Jenny Dörnemann et al. JOURNAL OF INFECTIOUS DISEASES
- Experimental Therapies for Ebola Virus Disease: What Have We Learned?
- (2017) Frederick G. Hayden et al. JOURNAL OF INFECTIOUS DISEASES
- Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
- (2017) Scott A. Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
- (2017) Dustin Siegel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular modeling, simulation and docking study of ebola virus glycoprotein
- (2017) Nasir Ahmad et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Improvements in treatment of children younger than age 5 years infected with Ebola virus
- (2017) Shu Yuan et al. JOURNAL OF PEDIATRICS
- Multivalent Glycosylated Nanostructures To Inhibit Ebola Virus Infection
- (2017) Beatriz M. Illescas et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles
- (2017) Marc Schweneker et al. JOURNAL OF VIROLOGY
- Cooperation of the Ebola Virus Proteins VP40 and GP 1,2 with BST2 To Activate NF-κB Independently of Virus-Like Particle Trapping
- (2017) Maryan G. Rizk et al. JOURNAL OF VIROLOGY
- Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model
- (2017) James Duehr et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment
- (2017) James Schuler et al. MOLECULES
- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
- (2017) Teresa Lambe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants
- (2017) Elizabeth Monreal-Escalante et al. PLANTA
- Use of convalescent plasma in Ebola virus infection
- (2017) Olivier Garraud TRANSFUSION AND APHERESIS SCIENCE
- Considerations for use of Ebola vaccine during an emergency response
- (2017) Jenny A. Walldorf et al. VACCINE
- Vaccines against Ebola virus
- (2017) Navin Venkatraman et al. VACCINE
- Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey
- (2017) Raj Kumar Singh et al. VETERINARY QUARTERLY
- Ebolavirus protein VP24 interferes with innate immune responses by inhibiting interferon-λ1 gene expression
- (2017) Felix He et al. VIROLOGY
- Ebola and Marburg virus vaccines
- (2017) Pierce Reynolds et al. VIRUS GENES
- Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
- (2017) Katie A. Howell et al. Cell Reports
- How to treat Ebola virus infections? A lesson from the field
- (2017) Sophie Duraffour et al. Current Opinion in Virology
- Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine
- (2017) Donata Medaglini et al. Current Opinion in Virology
- Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
- (2017) I. V. Dolzhikova et al. Human Vaccines & Immunotherapeutics
- Novel surveillance methods for the control of Ebola virus disease
- (2017) C. F. Houlihan et al. International Health
- QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient
- (2017) Pierangelo Chinello et al. PLoS Neglected Tropical Diseases
- The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study
- (2017) Kelly Skrable et al. PLoS Neglected Tropical Diseases
- The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
- (2017) Elizabeth A. Nelson et al. PLoS Neglected Tropical Diseases
- T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection
- (2017) Christopher L Cooper et al. Emerging Microbes & Infections
- Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
- (2017) Daouda Sissoko et al. Lancet Global Health
- A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus
- (2017) Sergio Rosales-Mendoza et al. Frontiers in Immunology
- Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
- (2017) Mandy Kader Konde et al. PLoS One
- The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?
- (2017) Peter D. Walsh et al. Scientific Reports
- Windows of opportunity for Ebola virus infection treatment and vaccination
- (2017) Van Kinh Nguyen et al. Scientific Reports
- Transient Production of Recombinant Pharmaceutical Proteins in Plants: Evolution and Perspectives
- (2017) Lilya Kopertekh et al. CURRENT MEDICINAL CHEMISTRY
- Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection
- (2016) Xiangguo Qiu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
- (2016) Manu Anantpadma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
- (2016) Xu Zhang et al. ANTIVIRAL RESEARCH
- Teicoplanin inhibits Ebola pseudovirus infection in cell culture
- (2016) Yizhuo Wang et al. ANTIVIRAL RESEARCH
- Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles
- (2016) Salma Teimoori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
- (2016) Zheng Zhao et al. BMC BIOINFORMATICS
- Ebola vaccine development plan: ethics, concerns and proposed measures
- (2016) Morenike Oluwatoyin Folayan et al. BMC Medical Ethics
- Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
- (2016) Andrew I. Flyak et al. CELL
- Ebola virus: A gap in drug design and discovery - experimental and computational perspective
- (2016) Marissa Balmith et al. Chemical Biology & Drug Design
- Ebola Virus Persistence in Semen of Male Survivors
- (2016) Timothy M. Uyeki et al. CLINICAL INFECTIOUS DISEASES
- Antiviral therapeutics for the treatment of Ebola virus infection
- (2016) Anthony P Cardile et al. CURRENT OPINION IN PHARMACOLOGY
- The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection
- (2016) Wenjiao Wu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The early clinical development of Ebola virus treatments
- (2016) Steven B. Bradfute EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Monoclonal antibodies for the treatment of Ebola virus disease
- (2016) A. L. Moekotte et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
- (2016) Reed F. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga
- (2016) Abhilash I. Chiramel et al. JOURNAL OF INFECTIOUS DISEASES
- Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
- (2016) Chad E. Mire et al. JOURNAL OF INFECTIOUS DISEASES
- An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral DrugsIn Vivounder Non-Biosafety Level 4 Conditions
- (2016) Dapeng Li et al. JOURNAL OF VIROLOGY
- The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats
- (2016) Michael Osterholm et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
- (2016) Gaurav Chopra et al. MOLECULES
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells
- (2016) Regina Ríos-Huerta et al. PLANT CELL REPORTS
- Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014
- (2016) Anna Kuehne et al. PLoS One
- B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets
- (2016) T. Yasmin et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses
- (2016) Anna Z. Wec et al. SCIENCE
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
- (2016) Z. A. Bornholdt et al. SCIENCE
- Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
- (2016) Karin Lövgren Bengtsson et al. VACCINE
- Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
- (2016) Lisa Henß et al. Virology Journal
- Recent advances in the development of vaccines for Ebola virus disease
- (2016) Elijah Ige Ohimain VIRUS RESEARCH
- Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies
- (2016) C. Geisen et al. VOX SANGUINIS
- Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications
- (2016) Elizabeth Nelson et al. Viruses-Basel
- Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication
- (2016) Michelle E. Olsen et al. mBio
- Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
- (2016) Zachary A. Bornholdt et al. mBio
- Inhibition of Ebola Virus by Anti-Ebola miRNAs in silico
- (2016) Zhabiz Golkar et al. Journal of Infection in Developing Countries
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
- (2016) Andrea Marzi et al. Scientific Reports
- Potent neutralizing monoclonal antibodies against Ebola virus infection
- (2016) Qi Zhang et al. Scientific Reports
- Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
- (2016) Katie A. Howell et al. Cell Reports
- Ebola vaccines in clinical trial: The promising candidates
- (2016) Yuxiao Wang et al. Human Vaccines & Immunotherapeutics
- Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis
- (2016) Feixiong Cheng et al. PLoS Computational Biology
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Containing Ebola at the Source with Ring Vaccination
- (2016) Stefano Merler et al. PLoS Neglected Tropical Diseases
- A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus
- (2016) Stephen D. S. McCarthy et al. PLoS Neglected Tropical Diseases
- Ecological Contexts of Index Cases and Spillover Events of Different Ebolaviruses
- (2016) Seth D. Judson et al. PLoS Pathogens
- Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations
- (2016) Lisa H. Cazares et al. Clinical Proteomics
- BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
- (2016) Raymond Taylor et al. Journal of Infection and Public Health
- Experimental Treatment of Ebola Virus Disease with Brincidofovir
- (2016) Jake Dunning et al. PLoS One
- Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge
- (2016) Krishnamurthy Konduru et al. PLoS One
- Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
- (2016) Yu Cong et al. PLoS One
- Discovery of an antibody for pan-ebolavirus therapy
- (2016) Wakako Furuyama et al. Scientific Reports
- Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
- (2016) John M. Dye et al. Scientific Reports
- A web-based resource for designing therapeutics against Ebola Virus
- (2016) Sandeep Kumar Dhanda et al. Scientific Reports
- Ebola Virus Disease: A Perspective for the United States
- (2015) Miguel G. Madariaga AMERICAN JOURNAL OF MEDICINE
- Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks
- (2015) Azizul Haque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular mechanisms of Ebola virus pathogenesis: focus on cell death
- (2015) L Falasca et al. CELL DEATH AND DIFFERENTIATION
- Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease
- (2015) Xiao-Xin Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
- (2015) Johan van Griensven et al. CLINICAL INFECTIOUS DISEASES
- Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead
- (2015) Everardo González-González et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Therapeutics for postexposure treatment of Ebola virus infection
- (2015) Marina Jerebtsova et al. Future Virology
- Plants as Factories for Human Pharmaceuticals: Applications and Challenges
- (2015) Jian Yao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
- (2015) Michelle Meyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
- (2015) Stuart D. Dowall et al. JOURNAL OF GENERAL VIROLOGY
- Novel Small Molecule Entry Inhibitors of Ebola Virus
- (2015) Arnab Basu et al. JOURNAL OF INFECTIOUS DISEASES
- Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All KnownEbolavirusSpecies
- (2015) Humberto Hernandez et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
- (2015) Gary Wong et al. JOURNAL OF INFECTIOUS DISEASES
- Overview of Ebola virus disease in 2014
- (2015) Chih-Peng Tseng et al. Journal of the Chinese Medical Association
- A thermostable, chromatographically purified Ebola nano-VLP vaccine
- (2015) John H Carra et al. Journal of Translational Medicine
- Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency
- (2015) Kendra J. Alfson et al. JOURNAL OF VIROLOGY
- Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
- (2015) Han Cheng et al. JOURNAL OF VIROLOGY
- Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses
- (2015) Frederick W. Holtsberg et al. JOURNAL OF VIROLOGY
- Favipiravir—a prophylactic treatment for Ebola contacts?
- (2015) Michel Van Herp et al. LANCET
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
- (2015) Emily P. Thi et al. NATURE
- Molecular Evidence of Sexual Transmission of Ebola Virus
- (2015) Suzanne E. Mate et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence of Ebola Virus in Ocular Fluid during Convalescence
- (2015) Jay B. Varkey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Ebola Virus Disease
- (2015) Paul E. Kilgore et al. PHARMACOTHERAPY
- Plant-made pharmaceuticals: from ‘Edible Vaccines’ to Ebola therapeutics
- (2015) Charles Arntzen PLANT BIOTECHNOLOGY JOURNAL
- Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents
- (2015) Stephen J. Streatfield et al. PLANT BIOTECHNOLOGY JOURNAL
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
- (2015) Yasuteru Sakurai et al. SCIENCE
- A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity
- (2015) Lisa M. Johansen et al. Science Translational Medicine
- A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus Disease
- (2015) Hidekazu Nishimura et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
- (2015) Travis K. Warren et al. mBio
- Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives
- (2015) Kuldeep Dhama et al. Journal of Infection in Developing Countries
- Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
- (2015) Rebecca J Grant-Klein et al. Human Vaccines & Immunotherapeutics
- Erratum to: Flavonoids as Multi-Target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies
- (2015) Utkarsh Raj et al. Interdisciplinary Sciences-Computational Life Sciences
- Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process
- (2015) Cristiano Salata et al. Pathogens and Disease
- Possible FDA-approved drugs to treat Ebola virus infection
- (2015) Shu Yuan Infectious Diseases of Poverty
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Potential and Emerging Treatment Options for Ebola Virus Disease
- (2014) Bryan M. Bishop ANNALS OF PHARMACOTHERAPY
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells
- (2014) Joshua C. Johnson et al. ANTIVIRAL RESEARCH
- Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
- (2014) Sophie J. Smither et al. ANTIVIRAL RESEARCH
- A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design
- (2014) Refat Sharmin et al. BMC BIOINFORMATICS
- Evaluating Novel Therapies During the Ebola Epidemic
- (2014) Steven Joffe JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Ebola Vaccine — An Urgent International Priority
- (2014) Rupa Kanapathipillai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro
- (2014) MiaoMiao Sheng et al. Science China-Life Sciences
- Fighting Ebola with ZMapp: spotlight on plant-made antibody
- (2014) YunFang Zhang et al. Science China-Life Sciences
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names
- (2014) Jens Kuhn et al. Viruses-Basel
- Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
- (2014) Takashi Nagata et al. Disaster Medicine and Public Health Preparedness
- Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
- (2014) Jonathan Audet et al. Scientific Reports
- First Ebola treatment is approved by WHO
- (2014) A. Gulland BMJ-British Medical Journal
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
- (2014) Jennifer Kouznetsova et al. Emerging Microbes & Infections
- Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment
- (2013) Jin Huk Choi et al. BIODRUGS
- An update on the use of antibodies against the filoviruses
- (2013) Erica Ollmann Saphire Immunotherapy
- Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus
- (2013) A. S. Herbert et al. JOURNAL OF VIROLOGY
- Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola
- (2013) Devon J Shedlock et al. MOLECULAR THERAPY
- A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
- (2013) Peter B. Madrid et al. PLoS One
- FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
- (2013) L. M. Johansen et al. Science Translational Medicine
- Multifaceted effects of hydroxychloroquine in human disease
- (2013) Nancy J. Olsen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The Secret Life of Viral Entry Glycoproteins: Moonlighting in Immune Evasion
- (2013) Jonathan D. Cook et al. PLoS Pathogens
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- Ebola virus entry requires the host-programmed recognition of an intracellular receptor
- (2012) Emily Happy Miller et al. EMBO JOURNAL
- Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
- (2012) Andrea Marzi et al. PLoS One
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase
- (2012) M. Garcia et al. Science Translational Medicine
- Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
- (2012) Patrick Iversen et al. Viruses-Basel
- A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge
- (2012) Rebecca J. Grant-Klein et al. Human Vaccines & Immunotherapeutics
- Identification of an antioxidant small-molecule with broad-spectrum antiviral activity
- (2011) Rekha G. Panchal et al. ANTIVIRAL RESEARCH
- Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin
- (2011) Andrey A. Kolokoltsov et al. ARCHIVES OF VIROLOGY
- DRBP76 Associates With Ebola Virus VP35 and Suppresses Viral Polymerase Function
- (2011) Reed S. Shabman et al. JOURNAL OF INFECTIOUS DISEASES
- Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
- (2011) Paulina Aleksandrowicz et al. JOURNAL OF INFECTIOUS DISEASES
- Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection
- (2011) O. Reynard et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
- (2011) Marceline Côté et al. NATURE
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
- (2011) A. S. Kondratowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
- (2011) Yoshimi Tsuda et al. PLoS Neglected Tropical Diseases
- Inhibition of heat-shock protein 90 reduces Ebola virus replication
- (2010) Darci R. Smith et al. ANTIVIRAL RESEARCH
- High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system
- (2010) Zhong Huang et al. BIOTECHNOLOGY AND BIOENGINEERING
- Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains
- (2010) K. Matsuno et al. JOURNAL OF VIROLOGY
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
- (2010) Thomas W Geisbert et al. LANCET
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- (2010) Travis K Warren et al. NATURE MEDICINE
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Development of a broad-spectrum antiviral with activity against Ebola virus
- (2009) M. Javad Aman et al. ANTIVIRAL RESEARCH
- Replication-Deficient Ebolavirus as a Vaccine Candidate
- (2009) P. Halfmann et al. JOURNAL OF VIROLOGY
- Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007
- (2009) Eric M. Leroy et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
- (2008) Jeffrey E. Lee et al. NATURE
- Generation of biologically contained Ebola viruses
- (2008) P. Halfmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started